Bacteria cause urinary tract infections (UTIs), so antibiotics are the first-line treatment. Even when symptoms disappear, a person should finish their antibiotic course according to their doctor’s ...

Panelists discuss how standard-of-care antibiotics for uncomplicated urinary tract infections (UTIs) show varying efficacy, with nitrofurantoin and fosfomycin ...

What Is Zaynich, and Why Does It Matter? Zaynich (cefepime and zidebactam) is an intravenous (IV) antibiotic that is FDA-approved for adults with complicated urinary tract infections (cUTIs) that are ...

Please provide your email address to receive an email when new articles are posted on . The mantra “shorter is better” for antibiotic durations has become a point of importance in the infectious ...

Cefepime-taniborbactam was 22% more effective than meropenem, which is a current treatment for complicated urinary tract infections (UTIs) and acute pyelonephritis, according to a study published in ...

Add Yahoo as a preferred source to see more of our stories on Google. UTIs are caused by bacteria like E. coli. But some infections are resistant to antibiotics. (Science Photo Library via Getty ...

US health regulators have approved a new antibiotic to treat urinary tract infections, a problem affecting more than 100 million people around the world, mainly women, British pharmaceutical giant GSK ...

In kids with a febrile urinary tract infection (UTI), an individualized duration of antibiotics led to an increased risk of recurrent UTI compared with a 10-day course. However, the individualized ...

Tebipenem pivoxil becomes the only FDA-approved oral carbapenem for complicated UTIs/pyelonephritis in adults lacking viable oral alternatives, potentially enabling earlier discharge and outpatient ...

MONDAY, June 22, 2026 (HealthDay News) -- The U.S. Food and Drug Administration has approved Utebzi (tebipenem pivoxil), an oral antibiotic, for the treatment of complicated urinary tract infections ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved gepotidacin (Blujepa, GSK), a new oral antibiotic for uncomplicated urinary tract infections (UTIs) in females aged 12 years ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...